Porth's Essentials of Pathophysiology, 4e

1183

Disorders of Skin Integrity and Function

C h a p t e r 4 6

14. Forbes HJ, Thomas SL, Langan SM. The epidemiology and prevention of herpes zoster. Curr Dermatol Rep. 2012;1:39–47. 15. Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160–166. 16. Goldman GS, King PG. Review of the United States universal varicella vaccination program: herpes zoster incidence rates, cost effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project Data. Vaccine. 2013;31(13):1680–1694. 17. Ramli R, Malik AS, Hani AFH, et al. Acne analysis, grading and computational assessment methods: an overview. Skin Res Technol. 2012;18:1–14. 18. Archer CB, Cohen SN, Baron SE. Guidance on the diagnosis and clinical management of acne. Clin Exp Dermatol. 2012;37:1–6. 19. Steventon K. Expert opinion and review article: the timing of comedone extraction in the treatment of premenstrual acne—a proposed therapeutic approach. Int J Cosmet Sci. 2010;33:99–104. 20. Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the lifespan. J Womens Health. 2010;21(2):223–230. 21. Jahns AC, Lundskog B, Ganceviciene R, et al. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study. Br J Dermatol. 2012;167:150–158. 22. Kurokawa I, Danby W, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821–832. 23. Shah SK, Alexis AF. Acne in skin color: practical approaches to treatment. J Dermatolog Treat. 2010;21:206–211. 24. Chauhan N, Ellis DA. Rosacea: pathophysiology and management principles. Facial Plast Surg Clin North Am. 2013;21(1):127–136. 25. Torpy JM, Schwartz LA, Golub RM. Rosacea. JAMA. 2012;307(21):3942. 26. van Zuuren EJ, Kramer SF, Carter BR, et al. Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. Br J Dermatol. 2011;165:760–781. 27. Rustemeyer T, van Hoogstraten MW, von Blomberg BME, et al. Mechanisms of irritant and allergic contact dermatitis. In: Johansen JD, Frosh PJ, Lepoittevin JP, eds. Contact Dermatitis . 5th ed. Dortmund, Germany: Springer; 2011:43–90. 28. Goodheart HP. Goodheart’s Photoguide to Common Skin Disorders . Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2009:51–59. 29. Cheong WK. Gentle cleansing and moisturizing for patients with atopic dermatitis and sensitive skin. Am J Clin Dermatol. 2009;10:13–17. 30. Zitelli KB, Cordoro KM. Evidence-based evaluation and management of chronic urticaria in children. Pediatr Dermatol. 2011;28(6):629–639. 31. Axelrod S, Davis-Lorton M. Urticaria and angioedema. Mt Sinai J Med. 2011;78:784–802. 32. Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012;51:889–902. 33. Diaz L, Ciurea AM. Cutaneous and systemic adverse reactions to antibiotics. Dermatol Ther. 2012;25:12–22. 34. Wolff K, Johnson RA, Saavedra AP, eds. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology . 7th ed. Chicago, IL: McGraw-Hill; 2013:488–507. 35. Khalili R, Bahria SL. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol. 2006;97:272–281. 36. Ziemer M, Kardaun SH, Liss Y, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with

lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. Br J Dermatol. 2012;166:575–600. 37. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(15):496–509. 38. Raho G, Koleva DM, Garattini L, et al. The burden of moderate to severe psoriasis: an overview. Pharmacoeconomics. 2012;30(11):1005–1013. 39. Cohen SN, Baron SE, Archer CB. Guidance on the diagnosis and clinical management of psoriasis. Clin Exp Dermatol. 2012;37:13–18. 40. Herrier RN. Advances in the treatment of moderate-to-severe plaque psoriasis. Am J Health Syst Pharm. 2011;68:795–806. 41. Kim IH, West CE, Kwatra SG, et al. Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol. 2012;3(6):365–374. 42. Goodheart HP. Goodheart’s Photoguide to Common Skin Disorders . Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2009:114–118. 43. Lehman JS, Tollefson MM, Gibson LE. Lichen planus. Int J Dermatol. 2009;48:682–694. 44. Martin-Brufau R, Corbalan-Berna J, Ramirez-Andreo A, et al. Personality differences between patients with lichen simplex chronicus and normal population: a study of pruritus. Eur J Dermatol. 2010;20(3):359–363. 45. Galadari HI, Gilchrest BA. Skin cancer prevention and sunscreens. In: Nouri K, ed. Skin Cancer . Chicago, IL: McGraw- Hill; 2008:643–647. 46. Bouzari N, Nouri K. Indoor tanning. In: Nouri K, ed. Skin Cancer . Chicago, IL: McGraw-Hill; 2008:672–678. 47. Land V, Small L. The evidence on how to best treat sunburn in children: a common treatment dilemma. Pediatr Nurs. 2008;34(4):343–348. 48. American Burn Association. Burn incidence and treatment in the United States: 2012 Fact Sheet. 2012. Available at: http:// ameriburn.org/resources_factsheet.php. Accessed October 5, 2013. 49. Price LA, Milner SM. The totality of burn care. Trauma. 2012;15(1):16–28. 50. Evers LH, Bhavsar D, Mailander P. The biology of burn injury. Exp Dermatol. 2010;19:777–783. 51. Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360(9):891–901. 52. van der Veen VC, Boekema BKHL, Ulrich MMW, et al. New dermal substitutes. Wound Repair Regen. 2011;19:S59–S65. 53. Agency for Healthcare Research and Quality. Preventing pressure ulcers in hospital: a toolkit for improving quality of care. 2013. Available at: http://www.ahqr.gov/reserach/ltc/ pressureulcertoolkit. Accessed October 13, 2013. 54. Alderden J, Whitney JD, Taylor SM, et al. Risk profile characteristics associated with outcomes of hospital-acquired pressure ulcers: a retrospective review. Crit Care Nurse. 2011;31(4):30–43. 55. Sprigle S, Sonenblum S. Assessing evidence supporting redistribution of pressure for pressure ulcer prevention: a review. J Rehabil Res Dev. 2011;48(3):203–214. 56. Reddy M. Pressure ulcers. Clin Evid (Online) 2011:1901. 57. National Pressure Ulcer Advisory Panel. NPUAP pressure ulcer stages/categories. 2013. Available at: http://www.npuap.org/ resources/educational-and-clinical-resources/npuap-pressure- ulcer-stagescategories/. Accessed October 5, 2013. 58. Goodheart HP. Goodheart’s Photoguide to Common Skin Disorders . Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2009:364–369. 59. Goodheart HP. Goodheart’s Photoguide to Common Skin Disorders . Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2009:370–374. 60. Clarke LE. Dyplastic nevi. Clin Lab Med. 2011;31(2):255–265.